Poland: Market for Medicaments Of Antibiotics other than Penicillins, Streptomycins or their Derivatives 2024

Market Size for Medicaments Of Antibiotics other than Penicillins, Streptomycins or their Derivatives in Poland

The Polish market for medicaments of antibiotics other than penicillins, streptomycins or their derivatives skyrocketed to $X in 2023, growing by X% against the previous year. Overall, consumption saw a relatively flat trend pattern. Over the period under review, the market reached the maximum level at $X in 2013; however, from 2014 to 2023, consumption stood at a somewhat lower figure.

Production of Medicaments Of Antibiotics other than Penicillins, Streptomycins or their Derivatives in Poland

In value terms, non-penicillin or streptomycin antibiotic medicaments production contracted slightly to $X in 2023 estimated in export price. Over the period under review, production, however, recorded a relatively flat trend pattern. The pace of growth appeared the most rapid in 2013 with an increase of X%. As a result, production attained the peak level of $X. From 2014 to 2023, production growth failed to regain momentum.

Exports of Medicaments Of Antibiotics other than Penicillins, Streptomycins or their Derivatives

Exports from Poland

In 2023, approx. X tons of medicaments of antibiotics other than penicillins, streptomycins or their derivatives were exported from Poland; waning by X% compared with the previous year. Overall, exports, however, enjoyed a prominent increase. The pace of growth appeared the most rapid in 2015 when exports increased by X% against the previous year. The exports peaked at X tons in 2021; however, from 2022 to 2023, the exports remained at a lower figure.

In value terms, non-penicillin or streptomycin antibiotic medicaments exports expanded sharply to $X in 2023. In general, exports, however, posted a buoyant expansion. The most prominent rate of growth was recorded in 2018 when exports increased by X%. The exports peaked in 2023 and are expected to retain growth in the immediate term.

Exports by Country

Russia (X tons), Vietnam (X tons) and Germany (X tons) were the main destinations of non-penicillin or streptomycin antibiotic medicaments exports from Poland, together accounting for X% of total exports. Italy, Spain, France, the Czech Republic, Austria, Mexico, the UK, Belarus, Slovakia and Slovenia lagged somewhat behind, together accounting for a further X%.

From 2012 to 2023, the biggest increases were recorded for Austria (with a CAGR of X%), while shipments for the other leaders experienced more modest paces of growth.

In value terms, Russia ($X) remains the key foreign market for medicaments of antibiotics other than penicillins, streptomycins or their derivatives exports from Poland, comprising X% of total exports. The second position in the ranking was held by the Czech Republic ($X), with a X% share of total exports. It was followed by Vietnam, with a X% share.

From 2012 to 2023, the average annual rate of growth in terms of value to Russia totaled X%. Exports to the other major destinations recorded the following average annual rates of exports growth: the Czech Republic (X% per year) and Vietnam (X% per year).

Export Prices by Country

The average export price for medicaments of antibiotics other than penicillins, streptomycins or their derivatives stood at $X per ton in 2023, surging by X% against the previous year. Over the period under review, the export price, however, recorded a perceptible contraction. The export price peaked at $X per ton in 2013; however, from 2014 to 2023, the export prices failed to regain momentum.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was Slovakia ($X per ton), while the average price for exports to Austria ($X per ton) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was recorded for supplies to Russia (X%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Medicaments Of Antibiotics other than Penicillins, Streptomycins or their Derivatives

Imports into Poland

In 2023, imports of medicaments of antibiotics other than penicillins, streptomycins or their derivatives into Poland soared to X tons, picking up by X% against 2022 figures. Over the period under review, total imports indicated resilient growth from 2012 to 2023: its volume increased at an average annual rate of X% over the last eleven-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, imports increased by X% against 2021 indices. As a result, imports attained the peak and are likely to continue growth in the immediate term.

In value terms, non-penicillin or streptomycin antibiotic medicaments imports surged to $X in 2023. The total import value increased at an average annual rate of X% from 2012 to 2023; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. As a result, imports attained the peak and are likely to continue growth in the immediate term.

Imports by Country

The Netherlands (X tons), Germany (X tons) and Spain (X tons) were the main suppliers of non-penicillin or streptomycin antibiotic medicaments imports to Poland, together accounting for X% of total imports. Italy, France, Slovenia, Denmark, Bulgaria, Belgium, Hungary and the UK lagged somewhat behind, together accounting for a further X%.

From 2012 to 2023, the most notable rate of growth in terms of purchases, amongst the main suppliers, was attained by Denmark (with a CAGR of X%), while imports for the other leaders experienced more modest paces of growth.

In value terms, the largest non-penicillin or streptomycin antibiotic medicaments suppliers to Poland were France ($X), Italy ($X) and Germany ($X), with a combined X% share of total imports. The Netherlands, Slovenia, Spain, Denmark, Bulgaria, Belgium, Hungary and the UK lagged somewhat behind, together accounting for a further X%.

Denmark, with a CAGR of X%, saw the highest growth rate of the value of imports, among the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The average import price for medicaments of antibiotics other than penicillins, streptomycins or their derivatives stood at $X per ton in 2023, increasing by X% against the previous year. Over the period under review, the import price showed a relatively flat trend pattern. The most prominent rate of growth was recorded in 2021 an increase of X% against the previous year. As a result, import price reached the peak level of $X per ton. From 2022 to 2023, the average import prices remained at a somewhat lower figure.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was France ($X per ton), while the price for Spain ($X per ton) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Slovenia (X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform